News

Psoriasis Patients Face Increased Risk of CVD

Publish date: November 11, 2011

 

EXPERT ANALYSIS FROM SDEF LAS VEGAS DERMATOLOGY SEMINAR

SDEF and this news organization are owned by Elsevier.

Pages

Recommended Reading

Scleroderma: Research Locally, Share Globally
MDedge Dermatology
Psoriatic Arthritis: Evidence Lacking for Widespread Methotrexate Use
MDedge Dermatology
Registry Updates Blau Diagnostic Criteria
MDedge Dermatology
Briakinumab Tops Methotrexate for Psoriasis in Phase III Study
MDedge Dermatology
New Psoriasis Biologics Achieve Promising Phase II Results
MDedge Dermatology
Adverse Effects Discourage Imatinib for Treatment of SSc
MDedge Dermatology
Adding Methotrexate to Etanercept Boosts Psoriasis Efficacy
MDedge Dermatology
FDA Steps Up Cancer Surveillance of TNF Blockers
MDedge Dermatology
New Lupus Nephritis Guidelines Will Address Therapy
MDedge Dermatology
Formula Calculates Need for Heart Catheterization in SSc
MDedge Dermatology